PHARMA-TECH A/S: Financial statements 2017
CVR: 32940897
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
PHARMA-TECH A/S (CVR 32940897) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 13,256,269 and a net result of DKK 3,366,523 compared with DKK 2,731,314 the year before. That is an increase of 12.9% compared with the year before. Equity in the 2017 report amounted to DKK 8,274,509. The solvency ratio was 56.3%. The company had 17 employees in the financial year.
- Gross Profit
- DKK 13,256,269
- Profit/Loss
- DKK 3,366,523
- Equity
- DKK 8,274,509
- Total Assets
- DKK 14,693,842
- Employees
- 17
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 13.3 mio. | 3.4 mio. | 8.3 mio. | 17 |
| 2016 | - | 11.7 mio. | 2.7 mio. | 6.9 mio. | - |
| 2015 | - | 12.5 mio. | 2.5 mio. | 5.7 mio. | - |
| 2014 | - | 11.2 mio. | 2.9 mio. | 7.2 mio. | - |
| 2013 | - | 10.2 mio. | 1.7 mio. | 4.4 mio. | 9 |
Keep an eye on PHARMA-TECH A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
PHARMA-TECH A/S has published its annual report for 2016. Gross profit came to DKK 11,736,503, and the net result was DKK 2,731,314.
As of March 31, 2017, Claus Wædeled has joined the board of directors of PHARMA-TECH A/S.
As of March 31, 2017, Peter Werner Fugmann has left the board of directors of PHARMA-TECH A/S.
As of March 30, 2017, Morten Hart Johansen is registered as adm. dir. of PHARMA-TECH A/S.
As of March 30, 2017, Ole Rubek has stepped down as adm. dir. of PHARMA-TECH A/S.
About PHARMA-TECH A/S
PHARMA-TECH A/S is a Danish company of the type Aktieselskab based in Randers SV, founded in 2010. The company is registered under the industry Fremstilling af plastemballage. The management consists of Morten Hart Johansen. The company is owned by JoWin Holding ApS. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 32,243,339 and a net result of DKK 5,636,893 compared with DKK 6,599,234 the year before. Equity in the 2025 report amounted to DKK 24,456,581.